{"version":"1.0","type":"link","title":"Corrigendum to \"Cost-effectiveness of multigene sequencing test and treatment for metastatic non-small cell lung cancer: A unique setting in the initial adoption phase in Japan allowing testing only after standard treatment\" [Heliyon Volume 10, Issue 19, October 2024, Article e37867].","author_name":"Shiraiwa N 외","author_url":"https://prs-insight.online/author/Shiraiwa%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100643","thumbnail_width":1200,"thumbnail_height":630}